Skip to main content

Table 2 A comparison of patient characteristics and radiation pneumonitis in lung cancer patients treated with tomotherapy according to the delivery mode of radiation beams

From: Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental rats

  

Mode of tomotherapy

P-value

Static

Helical

Smoking History

Yes

12/12 (83.3 %)

26/51 (51.0 %)

0.04

 

No

2/12 (16.7 %)

25/51 (49.0 %)

 

PTV (cc)

Median (range)

158.50 (57–799)

144.00 (16–789)

NS

Total lung V10 (%)

median (range)

32.00 (11–70)

44.00 (5–98)

NS

Total lung V20 (%)

median (range)

16.00 (5–51)

16.00 (4–53)

NS

CCRTx

Yes

7/12 (58.3 %)

14/51 (27.5 %)

0.04

 

No

5/12 (41.7 %)

37/51 (72.5 %)

 

Radiation pneumonitis scoring system

   

 RTOG

Acute

3/ 12 (25.0 %)

15/51 (29.4 %)

NS

 

Late

1/ 12 (8.3 %)

27/42 (64.3 %)

0.001

 CTCAE

Acute

3/ 12 (25.0 %)

20/51 (39.2 %)

NS

 

Late

1/ 12 (8.3 %)

20/42 (47.6 %)

0.01

  1. CCRTx concurrent chemoradiotherapy, RTOG Radiation Therapy Oncology Group, CTCAE the National Cancer Institute Common Terminology Criteria for Adverse Events, version 3.0, NS not significant